Fibroblast Reprogramming Using Viral Vectors for iPSC Generation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating induced pluripotent stem cells (iPSCs) are inefficient and lack standardized protocols for reprogramming fibroblasts into iPSCs, which hinders their therapeutic applications in regenerative medicine.
Innovation Solution
A method involving the reprogramming of fibroblast cells using a polynucleotide encoding a reprogramming factor, followed by transfer to a reprogramming medium, expansion, and identification of confluent iPSCs, with optional steps of freezing and differentiation into specific cell lineages, utilizing viral vectors like lentiviral or sendaiviral vectors to encode factors such as Oct3/4, Sox2, and Klf4, and culturing in media like mTeSR1 for expansion.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If current methods for generating iPSCs are used, then iPSCs can be produced, but the efficiency is low and standardized protocols are lacking
Solution Approach 1:
The patent applies parameter changes by systematically optimizing culture medium composition (adding specific growth factors like bFGF, LIF, and insulin), adjusting reprogramming factor expression levels, and modifying culture conditions (temperature, CO2 levels) to enhance iPSC generation efficiency while establishing reproducible protocols
Solution Approach 2:
The reprogramming process is segmented into distinct phases: initial reprogramming phase with specific factors, transition phase to reprogramming medium, and expansion phase. This segmentation allows optimization of each stage independently, improving overall efficiency and enabling standardized protocols for each step
2Reliability
If fibroblasts are reprogrammed using polynucleotides encoding reprogramming factors, then iPSCs are generated, but the process lacks standardization
Solution Approach 1:
The patent employs preliminary action by pre-establishing optimized culture mediums with specific growth factors, pre-defining reprogramming factor combinations (Oct3/4, Sox2, Klf4, c-Myc), and pre-setting culture conditions before initiating reprogramming. This preliminary preparation ensures reliable and standardized iPSC generation across different experiments
Solution Approach 2:
The patent implements feedback mechanisms by monitoring iPSC colony formation, characterizing cell morphology and marker expression (Oct4, Nanog, TRA-1-60), and adjusting culture conditions based on reprogramming efficiency. This feedback loop enables optimization and standardization of the reprogramming protocol
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method effectively generates high-quality iPSCs that can be differentiated into various cell types, offering a standardized approach for therapeutic applications and autologous transplantation, enhancing the efficiency and reliability of iPSC production.
Implementation Method 1
reprogramming the plurality of fibroblast cells by delivering to the plurality of fibroblast cells a polynucleotide encoding a reprogramming factor
Data Source
AI summary
In some embodiments, the present disclosure is directed to methods of reprogramming fibroblasts into induced pluripotent stem cells. In some embodiments, a method comprises obtaining fibroblasts, such as from a skin biopsy. In some embodiments, a method comprises reprogramming fibroblasts using a viral vector encoding reprogramming factors. In some embodiments, a method comprises expanding iPSC and identifying confluent iPSC.